ArticlePhysics and imaging in radiation oncology2026
Tumor-conditioned inter-patient registration using planning computed tomography for voxel-based analysis to predict radiation pneumonitis in lung cancer patients.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background and purpose: Deformable image registration (DIR) for voxel-based analysis (VBA) can be challenging in patients with non-small cell lung cancer (NSCLC) due to large variations in tumor size and location. This study aimed to assess whether a tumor-preserving inter-patient DIR approach improves VBA-based prediction of radiation pneumonitis (RP). Methods and materials: Three DIR methods were evaluated: deep learning-based Tumor-Aware Recurrent Registration (TRACER) and Patient-Specific Context and Shape (PACS), trained on a public dataset of 268 locally-advanced (LA) NSCLC patients, and iterative Symmetric Normalization (SyN). All methods were tested on 240 patients with LA-NSCLC. Geometric, dosimetric, and tumor preservation metrics were compared using the Wilcoxon signed-rank test. VBA was conducted with each DIR method to identify cohort-relevant regions (CRRs). Machine learning models incorporating clinical, dosimetric, and CRR dose features were used to predict grade 2 or higher RP. Results: TRACER best preserved tumor volume (1.39 %) and organ doses (mean 0.08 Gy) compared with PACS and SyN (p < 0.001). PACS showed higher geometric but worse dose preservation accuracy than TRACER. All DIR-based VBA methods identified the right lung as the CRR associated with RP. TRACER-derived CRR had slightly higher RP predictive performance (AUC 0.78 vs PACS 0.73 vs SyN 0.71), and outperformed the MLD-based ML model (AUC = 0.78 vs 0.69, p = 0.04; specificity = 0.62 vs 0.48). Conclusions: TRACER improved registration accuracy, with better tumor volume preservation and reduced OAR dose impact. Incorporating VBA-derived dose enhanced RP prediction accuracy compared with using MLD. CRRs identified through VBA were robust to the choice of DIR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.